SearchRon Zuckerman
Ron Zuckerman has been active as a tech entrepreneur and investor for most of the last 25 years. He was one of the founders of Sapiens International, a software company he took public on NASDAQ in 1990 andis currently trading with a market cap of over $700m. Mr Zuckerman acted as chair and chief executive of Sapiens from early 1995 to late 1999. He was the founder and executive chair of Precise Software Solutions, another software company he took public on NASDAQ in 2000 until its acquisition in late 2003 by VERITAS, in a cash transaction valued at over $600 Million. Mr Zuckerman was a founder, first round investor and a board member in GVT Holding SA, a large telephone operator in Brazil, until its acquisition in late 2009 by The Vivendi Group of France for over $4.7 Billion. He was an early investor and a board member at Wintegra, which was acquired in 2010 by PMC Sierra for over $200m.
In 2000, Mr Zuckerman was chosen by the World Economic Forum as leading one of the most influential tech ventures (ie Sapiens), together with such individuals as Masayoshi Son of SoftBank Group, Jerry Yang of Yahoo! and Michael Dell of Dell Computers.
Bio last updated 15 Apr 2017
Access to our data for Ron Zuckerman is only available to paid subscribers with BNiQ access.
The BNiQ search engine is Western Australia's most accurate and comprehensive business listings and searchable database.
Ron Zuckerman is linked to 1 organisation which is included in 2 lists - Technology Companies and Public Companies - Industrial.
To see the data you will need to subscribe.
Total Shareholder Return as at 31/10/18
| 1 year TSR | 5 year TSR | ||
|---|---|---|---|
| 9th | BARD1 Life Sciences | 445% | 10% |
| 148th | Dragontail Systems | 33% | 0% |
| 450th | PainChek | -17% | -17% |
| 514th | MGC Pharmaceuticals | -25% | 36% |
| 826th | Servtech Global Holdings | -80% | 0% |
744 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Source: Morningstar
Source: Morningstar
Roles
Year started and most recent title
Revenue
| 182nd |  | PainChek | $434k |
| 183rd |  | Servtech Global Holdings | $430k |
| 184th |  | Dragontail Systems | $419k |
| 185th | | MGC Pharmaceuticals | $403k |
| 186th | | BARD1 Life Sciences | $365k |
240 listed industrial companies ranked by revenue.
Source: Morningstar
Source: Morningstar
BNiQ Disclaimer
Some of the information on ASX-listed public companies is sourced from Morningstar Australasia Pty Ltd (ABN: 95 090 665 544).
It is important to note that the Morningstar information displayed by Business News is not to be copied or distributed except as authorised; and that such information is not warranted to be accurate, complete or timely and that neither Morningstar nor Business News are responsible for any damages or losses arising from any use of this information.
The information is general information only and does not constitute financial advice It is not intended to be, and should not be construed in any way as, investment, legal or financial advice
Retail clients should be advised the Morningstar Financial Services Guide can be found at http://www.morningstar.com.au/fsg.asp
Show moreIt is important to note that the Morningstar information displayed by Business News is not to be copied or distributed except as authorised; and that such information is not warranted to be accurate, complete or timely and that neither Morningstar nor Business News are responsible for any damages or losses arising from any use of this information.
The information is general information only and does not constitute financial advice It is not intended to be, and should not be construed in any way as, investment, legal or financial advice
Retail clients should be advised the Morningstar Financial Services Guide can be found at http://www.morningstar.com.au/fsg.asp
